Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Bladder Cancer

  Free Subscription


20.02.2023

1 Am J Cancer Res
1 Am J Clin Nutr
1 Ann Surg Oncol
1 Biom J
1 bioRxiv
1 BMC Urol
1 Cancer Biomark
1 Cancer Res
8 Cancers (Basel)
1 Cell Death Dis
1 Cells
1 Cent European J Urol
1 Chem Biol Drug Des
1 Clin Cancer Res
1 Clin Genitourin Cancer
1 Drug Resist Updat
1 EMBO J
1 Eur J Radiol
2 Eur Urol Oncol
1 Expert Opin Pharmacother
1 Front Genet
3 Front Immunol
1 Front Oncol
1 Future Sci OA
1 Gan To Kagaku Ryoho
1 Int J Environ Res Public Health
3 Int J Mol Sci
1 Int J Surg
2 Int J Urol
1 J Fluoresc
1 J Laparoendosc Adv Surg Tech A
2 J Transl Med
6 J Urol
2 Lab Invest
1 Med Ultrason
1 Mod Pathol
1 Oncologist
1 Pediatr Int
1 Saudi J Biol Sci
1 Scott Med J
3 Urol Oncol
1 Urologie
5 Urology
1 Zhonghua Zhong Liu Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cancer Res

  1. DE SOUZA AL, Mega AE, Douglass J, Olszewski AJ, et al
    Clinical features of patients with MTAP-deleted bladder cancer.
    Am J Cancer Res. 2023;13:326-339.
    PubMed         Abstract available


    Am J Clin Nutr

  2. VAN ZUTPHEN M, Hof JP, Aben KK, Kampman E, et al
    Adherence to lifestyle recommendations after non-muscle invasive bladder cancer diagnosis and risk of recurrence.
    Am J Clin Nutr. 2023 Feb 11:S0002-9165(23)04155.
    PubMed         Abstract available


    Ann Surg Oncol

  3. AMINOLTEJARI K, Hird AE, Klaassen Z, Satkunasivam R, et al
    Robotic Versus Open Cystectomy for Bladder Cancer: Synthesizing the Data from Current Systematic Reviews and Meta-Analyses.
    Ann Surg Oncol. 2023 Feb 11. doi: 10.1245/s10434-022-12692.
    PubMed         Abstract available


    Biom J

  4. SUN H, Wang X
    High-dimensional feature selection in competing risks modeling: A stable approach using a split-and-merge ensemble algorithm.
    Biom J. 2023;65:e2100164.
    PubMed         Abstract available


    bioRxiv

  5. WONG JL, Smith P, Angulo-Lozano J, Ranti D, et al
    IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer.
    bioRxiv. 2023 Feb 1:2023.01.30.526266. doi: 10.1101/2023.01.30.526266.
    PubMed         Abstract available


    BMC Urol

  6. LIU P, Xu L, Chen G, Shi B, et al
    Nomograms for predicting survival in patients with micropapillary bladder cancer: a real-world analysis based on the surveillance, epidemiology, and end results database and external validation in a tertiary center.
    BMC Urol. 2023;23:16.
    PubMed         Abstract available


    Cancer Biomark

  7. MOLLER K, Knoll M, Bady E, Schmerder MJ, et al
    PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples.
    Cancer Biomark. 2023;36:177-191.
    PubMed         Abstract available


    Cancer Res

  8. CASWELL D, Swanton C
    Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer.
    Cancer Res. 2023;83:487-488.
    PubMed         Abstract available


    Cancers (Basel)

  9. KAMECKI H, Debowska M, Poleszczuk J, Demkow T, et al
    Incidental Diagnosis of Urothelial Bladder Cancer: Associations with Overall Survival.
    Cancers (Basel). 2023;15:668.
    PubMed         Abstract available

  10. LIU J, Zhou Z, Jiang Y, Lin Y, et al
    EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer.
    Cancers (Basel). 2023;15:621.
    PubMed         Abstract available

  11. LEONARDO C, Flammia RS, Lucciola S, Proietti F, et al
    Performance of Node-RADS Scoring System for a Standardized Assessment of Regional Lymph Nodes in Bladder Cancer Patients.
    Cancers (Basel). 2023;15:580.
    PubMed         Abstract available

  12. PAPAVASILIOU E, Sills VA, Calanzani N, Harrison H, et al
    Diagnostic Performance of Biomarkers for Bladder Cancer Detection Suitable for Community and Primary Care Settings: A Systematic Review and Meta-Analysis.
    Cancers (Basel). 2023;15:709.
    PubMed         Abstract available

  13. ZHANG Y, Wang W, Zhou H, Cui Y, et al
    Urinary Eubacterium sp. CAG:581 Promotes Non-Muscle Invasive Bladder Cancer (NMIBC) Development through the ECM1/MMP9 Pathway.
    Cancers (Basel). 2023;15:809.
    PubMed         Abstract available

  14. AFONSO J, Goncalves C, Costa M, Ferreira D, et al
    Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy.
    Cancers (Basel). 2023;15:982.
    PubMed         Abstract available

  15. ESTEBAN-VILLARRUBIA J, Torres-Jimenez J, Bueno-Bravo C, Garcia-Mondaray R, et al
    Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2023;15:566.
    PubMed         Abstract available

  16. PAPPOT H, Ullen A
    Optimal Systemic Treatment of Advanced Bladder Cancer Calls for a Multidisciplinary Approach.
    Cancers (Basel). 2023;15:559.
    PubMed         Abstract available


    Cell Death Dis

  17. ZHANG Z, Mou Z, Xu C, Wu S, et al
    Correction: Autophagy-associated circular RNA hsa_circ_0007813 modulates human bladder cancer progression via hsa-miR-361-3p/IGF2R regulation.
    Cell Death Dis. 2023;14:113.
    PubMed        


    Cells

  18. KOWALD S, Huge Y, Tandiono D, Ali Z, et al
    Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer.
    Cells. 2023;12:508.
    PubMed         Abstract available


    Cent European J Urol

  19. TAPPERO S, Sorce G, Panunzio A, Hohenhorst L, et al
    Efficacy of chemotherapy on overall survival in metastatic sarcomatoid bladder cancer patients.
    Cent European J Urol. 2022;75:352-356.
    PubMed         Abstract available


    Chem Biol Drug Des

  20. YANG Z, Bi Y, Xu W, Guo R, et al
    Glabridin inhibits urothelial bladder carcinoma cell growth in vitro and in vivo by inducing cell apoptosis and cell cycle arrest.
    Chem Biol Drug Des. 2023;101:581-592.
    PubMed         Abstract available


    Clin Cancer Res

  21. CHRISTENSEN E, Nordentoft I, Birkenkamp-Demtroder K, Elbaek SK, et al
    Cell-free urine- and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle invasive bladder cancer.
    Clin Cancer Res. 2023 Feb 13:CCR-22-3250. doi: 10.1158/1078-0432.CCR-22-3250.
    PubMed         Abstract available


    Clin Genitourin Cancer

  22. VON DEIMLING M, Schuettfort VM, D'Andrea D, Pradere B, et al
    Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy.
    Clin Genitourin Cancer. 2023 Jan 26:S1558-7673(23)00031.
    PubMed         Abstract available


    Drug Resist Updat

  23. LI F, Zheng Z, Chen W, Li D, et al
    Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms.
    Drug Resist Updat. 2023;68:100938.
    PubMed         Abstract available


    EMBO J

  24. SHIGETA K, Hasegawa M, Hishiki T, Naito Y, et al
    IDH2 stabilizes HIF-1alpha-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer.
    EMBO J. 2023;42:e110620.
    PubMed         Abstract available


    Eur J Radiol

  25. TSILI AC, Varkarakis I, Pasoglou V, Anagnostou N, et al
    CT of the urinary tract revisited.
    Eur J Radiol. 2023;160:110717.
    PubMed         Abstract available


    Eur Urol Oncol

  26. ARITA Y, Yoshida S, Shigeta K, Kwee TC, et al
    Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology.
    Eur Urol Oncol. 2023;6:99-102.
    PubMed         Abstract available

  27. HUYNH MA, Tang C, Siva S, Berlin A, et al
    Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers.
    Eur Urol Oncol. 2023;6:28-38.
    PubMed         Abstract available


    Expert Opin Pharmacother

  28. BIANCHI A, von Deimling M, Pallauf M, Yanagisawa T, et al
    Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond.
    Expert Opin Pharmacother. 2023;24:177-195.
    PubMed         Abstract available


    Front Genet

  29. LI S, Jiang M, Yang L, Zheng F, et al
    Identification of platinum resistance-related gene signature for prognosis and immune analysis in bladder cancer.
    Front Genet. 2023;14:1062060.
    PubMed         Abstract available


    Front Immunol

  30. KIMURA Y, Fujimori M, Rajagopalan NR, Poudel K, et al
    Macrophage activity at the site of tumor ablation can promote murine urothelial cancer via transforming growth factor-beta1.
    Front Immunol. 2023;14:1070196.
    PubMed         Abstract available

  31. LOPES S, Pabst L, Dory A, Klotz M, et al
    Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis.
    Front Immunol. 2023;14:1070076.
    PubMed         Abstract available

  32. SUN Z, Jing C, Zhan H, Guo X, et al
    Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine.
    Front Immunol. 2023;14:1097472.
    PubMed         Abstract available


    Front Oncol

  33. YANG Y, Wang C, Li Z, Lu Q, et al
    Precise diagnosis and treatment of non-muscle invasive bladder cancer - A clinical perspective.
    Front Oncol. 2023;13:1042552.
    PubMed         Abstract available


    Future Sci OA

  34. AL-ZUBI MT, Demour SA, Al-Rawashdah SF, Carbone A, et al
    Does post-void residual urine volume affect potential recurrence risk for non-muscle invasive bladder cancer?
    Future Sci OA. 2023;8:FSO823.
    PubMed         Abstract available


    Gan To Kagaku Ryoho

  35. HATAKEYAMA S, Ohyama C
    [Ⅱ. Update on Guideline for Management of Metastatic Urothelial Carcinoma].
    Gan To Kagaku Ryoho. 2023;50:45-49.
    PubMed        


    Int J Environ Res Public Health

  36. HAGHAYEGH S, Liu Y, Zhang Y, Strohmaier S, et al
    Rotating Night Shift Work and Bladder Cancer Risk in Women: Results of Two Prospective Cohort Studies.
    Int J Environ Res Public Health. 2023;20:2202.
    PubMed         Abstract available


    Int J Mol Sci

  37. TERANISHI K
    In Vivo Optical Imaging of Bladder Cancer Tissues in an MB49 Bladder Cancer Orthotopic Mouse Model Using the Intravesical or Intravenous Administration of Near-Infrared Fluorescence Probe.
    Int J Mol Sci. 2023;24:2349.
    PubMed         Abstract available

  38. GIANNIOU DD, Sklirou AD, Papadimitriou MA, Pilala KM, et al
    Evaluation of the Small Heat Shock Protein Family Members HSPB2 and HSPB3 in Bladder Cancer Prognosis and Progression.
    Int J Mol Sci. 2023;24:2609.
    PubMed         Abstract available

  39. ZHENG Q, Jiang Z, Ni X, Yang S, et al
    Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer.
    Int J Mol Sci. 2023;24:2746.
    PubMed         Abstract available


    Int J Surg

  40. TAN Z, Wang H, Wang J
    A commentary on 'systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer' (Int J S
    Int J Surg. 2023;109:208-210.
    PubMed        


    Int J Urol

  41. MIYAMOTO T, Miyake M, Nakahama T, Nishimura N, et al
    Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non-muscle invasive bladder cancer: A multi-institutional collaborative study.
    Int J Urol. 2023 Feb 14. doi: 10.1111/iju.15162.
    PubMed         Abstract available

  42. YANG H, Zhang Z, Zhao K, Zhang Y, et al
    Initial experience with 161 extraperitoneal laparoscopic radical cystectomy procedures: Comparison with transabdominal laparoscopic radical cystectomy.
    Int J Urol. 2023;30:155-160.
    PubMed         Abstract available


    J Fluoresc

  43. MALEK-ESFANDIARI Z, Rezvani-Noghani A, Sohrabi T, Mokaberi P, et al
    Molecular Dynamics and Multi-Spectroscopic of the Interaction Behavior between Bladder Cancer Cells and Calf Thymus DNA with Rebeccamycin: Apoptosis through the Down Regulation of PI3K/AKT Signaling Pathway.
    J Fluoresc. 2023 Feb 14. doi: 10.1007/s10895-023-03169.
    PubMed         Abstract available


    J Laparoendosc Adv Surg Tech A

  44. TUO Z, Wang J, Zhang Y, Bi L, et al
    Learning Curve of a Novel Three-Port Laparoscopic Radical Cystectomy with Urinary Diversion: A Single-Center Retrospective Analysis.
    J Laparoendosc Adv Surg Tech A. 2023;33:188-193.
    PubMed         Abstract available


    J Transl Med

  45. GANJI M, Bakhshi S, Shoari A, Ahangari Cohan R, et al
    Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer.
    J Transl Med. 2023;21:111.
    PubMed         Abstract available

  46. KOLL FJ, Banek S, Kluth L, Kollermann J, et al
    Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis.
    J Transl Med. 2023;21:124.
    PubMed         Abstract available


    J Urol

  47. MYERS A, Frank I, Shah PH, Tarrell RF, et al
    Intraoperative Blood Transfusion Is Associated With Increased Risk of Venous Thromboembolism After Radical Cystectomy.
    J Urol. 2023;209:525-531.
    PubMed         Abstract available

  48. PALLAUF M, D'Andrea D, Konig F, Laukhtina E, et al
    Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study.
    J Urol. 2023;209:515-524.
    PubMed         Abstract available

  49. TISSOT G, Xylinas E
    Lymph Node Dissection in Upper Tract Urothelial Cancer: Ready for Prime Time?
    J Urol. 2023;209:462-463.
    PubMed        

  50. MASTROIANNI R, Ochoa Arvizo MA, Torregiani G, Simone G, et al
    Robot-assisted vs Open Radical Cystectomy: Randomized Controlled Trials Lights and Shadows.
    J Urol. 2023;209:460-461.
    PubMed        

  51. VANDEN BERG RNW, Abern M
    National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. Letter.
    J Urol. 2023;209:508.
    PubMed        

  52. PRUNTY M, Shoag J
    National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. Reply.
    J Urol. 2023;209:508-509.
    PubMed        


    Lab Invest

  53. SHAFI S, Aung TN, Xirou V, Gavrielatou N, et al
    Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer.
    Lab Invest. 2022;102:1143-1149.
    PubMed         Abstract available

  54. WANG L, Wu S, He H, Ai K, et al
    CircRNA-ST6GALNAC6 increases the sensitivity of bladder cancer cells to erastin-induced ferroptosis by regulating the HSPB1/P38 axis.
    Lab Invest. 2022;102:1323-1334.
    PubMed         Abstract available


    Med Ultrason

  55. ZHU J, Huang X, Liu L, Wang N, et al
    Can the Vesical Imaging Reporting and Data System (VI-RADS) score be applied in conventional ultrasound and contrast-enhanced ultrasound to differentiate muscle-invasive bladder cancer?
    Med Ultrason. 2023 Feb 7. doi: 10.11152/mu-3841.
    PubMed         Abstract available


    Mod Pathol

  56. ACOSTA AM, Demicco EG, Dal Cin P, Hirsch MS, et al
    Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions.
    Mod Pathol. 2021;34:469-477.
    PubMed         Abstract available


    Oncologist

  57. JARDIM DLF, Millis SZ, Ross JS, Lippman S, et al
    Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors.
    Oncologist. 2023;28:e82-e91.
    PubMed         Abstract available


    Pediatr Int

  58. MOMO OM, Otake S, Minamikawa S, Ohkusu K, et al
    Painless subcutaneous abscess caused by bacillus Calmette-Guerin osteomyelitis.
    Pediatr Int. 2023;65:e15381.
    PubMed        


    Saudi J Biol Sci

  59. SEVIM NALKIRAN H, Akcora Yildiz D, Saydam F, Guzel AI, et al
    Targeting the anaphase-promoting complex/cyclosome (APC/C) enhanced antiproliferative and apoptotic response in bladder cancer.
    Saudi J Biol Sci. 2023;30:103564.
    PubMed         Abstract available


    Scott Med J

  60. ANBARASAN T, Nissar S, Turbitt J, Walls K, et al
    Urinary bladder recurrences following ureteroscopic biopsies of upper tract urothelial cancers: a multi-centre observational study with genomic assessment for clonality.
    Scott Med J. 2023;68:4-13.
    PubMed         Abstract available


    Urol Oncol

  61. SMELSER WW, Tallman JE, Gupta VK, Al Hussein Al Awamlh B, et al
    Implementation of a comprehensive prehabilitation program for patients undergoing radical cystectomy.
    Urol Oncol. 2023;41:108.
    PubMed         Abstract available

  62. ALSYOUF M, Ladi-Seyedian SS, Konety B, Pohar K, et al
    Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?
    Urol Oncol. 2023;41:109.
    PubMed         Abstract available

  63. RAHMAN SN, Lokeshwar SD, Syed JS, Javier-Desloges JF, et al
    Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder.
    Urol Oncol. 2023;41:107.
    PubMed         Abstract available


    Urologie

  64. YIRGA L, Hadaschik B, Burger M, Pullen L, et al
    [Photodynamic TUR-B: it looks better than it is : Comment on the randomized study].
    Urologie. 2023;62:181-183.
    PubMed        


    Urology

  65. ALSYOUF M, Daneshmand S
    Late Complication of Orthotopic T-Pouch Ileal Neobladder Diversion.
    Urology. 2023;172:e1-e2.
    PubMed        

  66. MAKEDON AM, Sadowsky A, Johnson BA, Walker DT, et al
    A Novel Technique of Robotic-Assisted Simple Cystectomy During Urinary Diversion for Benign Indications.
    Urology. 2023;172:234.
    PubMed         Abstract available

  67. BRITTON CJ, Gottlich HC, Tarrell RF, Thapa P, et al
    Perioperative and Oncologic Outcomes Associated with Simultaneous Radical Cystectomy and Nephroureterectomy.
    Urology. 2023;172:149-156.
    PubMed         Abstract available

  68. SUBIELA JD, Gonzalez-Padilla DA, Huguet J, Aumatell J, et al
    Oncological and Renal Function Outcomes in Patients Who Underwent Simultaneous Radical Cystectomy and Nephroureterectomy for Synchronous or Metachronous Panurothelial Carcinoma.
    Urology. 2023;172:157-164.
    PubMed         Abstract available

  69. DOPPALAPUDI SK, Chua KJ, Tabakin AL, Park JH, et al
    Chemotherapy Refractory Spindle-Cell Rhabdomyosarcoma of the Bladder Treated with Consolidative Ovarian-Sparing Radical Surgery.
    Urology. 2022 Nov 16:S0090-4295(22)00953-0. doi: 10.1016/j.urology.2022.
    PubMed         Abstract available


    Zhonghua Zhong Liu Za Zhi

  70. ZHONG SJ, Gao JJ, Tang P, Liu YP, et al
    [The efficacy of radiotherapy based combined therapy for unresectable locally invasive bladder cancer and its associated factors analysis].
    Zhonghua Zhong Liu Za Zhi. 2023;45:175-181.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: